Alterity Therapeutics (ATHE) Change in Cash (2016 - 2019)

Alterity Therapeutics' Change in Cash history runs 4 years deep, the most recent figure standing at -$1.6 million for Q4 2019.

• In Q4 2019, Change in Cash rose 68.41% year-over-year to -$1.6 million; the TTM figure through Dec 2019 stood at -$8.2 million (changed N/A YoY), while the FY2025 annual figure was $13.3 million, up 692.99% from the prior year.
• Change in Cash was -$1.6 million for Q4 2019 at Alterity Therapeutics, up from -$5.1 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of -$598231.8 in Q4 2016 to a low of -$5.1 million in Q4 2018.
• Historically, Change in Cash has averaged -$2.1 million across 4 years, with a median of -$1.3 million in 2017.
• The sharpest annual moves came in 2018 and 2019: Change in Cash tumbled 444.27% in 2018, then soared 68.41% in 2019.
• A 4-year view of Change in Cash shows it stood at -$598231.8 in 2016, then plunged by 56.04% to -$933486.7 in 2017, then sank by 444.27% to -$5.1 million in 2018, then jumped by 68.41% to -$1.6 million in 2019.
• The last three Change in Cash figures came in at -$1.6 million (Q4 2019), -$5.1 million (Q4 2018), and -$933486.7 (Q4 2017), per Business Quant data.